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ABSTRACT 1 
By rewiring the sporulation gene-regulatory network of Bacillus subtilis, we 2 
generated a novel expression system relying on de-repression. The gene of 3 
interest is placed under control of the abrB promoter, which is only active when 4 
Spo0A is absent, and Spo0A is controlled via an IPTG-inducible promoter.  5 
 6 
Short form paper 7 
We designed a novel system to express and secrete (heterologous) proteins in B. 8 
subtilis. Instead of using an inducer to activate protein production, we made use of a 9 
de-repression system. This allows growth of the host to high cell densities in the 10 
presence of the inducer. Upon removal of the inducer, high expression levels are 11 
obtained. To generate such a system, we made use of the well-studied sporulation 12 
phosphorelay of B. subtilis. 13 
Controlled de-repression of abrB by relief of Spo0A 14 
As an adaptive ability in response to starvation, B. subtilis is able to form highly 15 
resistant endospores (13). The process of sporulation is governed by a 16 
multicomponent phosphorelay (11). Multiple environmental and physiological signals 17 
are fed into this system, and under appropriate conditions this leads to 18 
phosphorylation of Spo0A (0A), the key sporulation transcription factor (1). A major 19 
role of Spo0A~P (0A~P) is to repress abrB expression (8,10).  20 
In the absence of Spo0A~P, abrB gene expression is constitutively high (12). To test 21 
whether we could use this feature of the sporulation pathway to construct a de-22 
repression system to express heterologous proteins in B. subtilis, we cloned the gene 23 
encoding the Green Fluorescent Protein (GFP) behind the abrB promoter (Fig. 1). In 24 
3 
the resulting strain (17) cells highly express GFP during exponential growth, and 1 
fluorescence is reduced upon entry into the stationary growth phase (data not shown). 2 
Ireton et al. have shown that the abrB promoter is repressed by artificial induction of 3 
Spo0A-Sad67 (hereafter called 0A*), a constitutively active variant of Spo0A (3). 4 
Knowing this, we introduced the IPTG inducible 0A* construct in our PabrB-gfp, 5 
hereafter called (A-gfp) strain. All bacterial strains and plasmids used in this study are 6 
listed in Table 1. Bacteria were grown and transformed using standard techniques.  7 
Flow cytometric measurement of GFP fluorescence 8 
Cells were grown overnight in TY containing 100 µM IPTG and diluted 30x to an 9 
OD600 of 0.05. At an OD600 of ~1,0 cells were diluted 10x in minimal medium and a 1 10 
ml suspension (without glass beads) was treated with a Mini-Bead-Beater-8 (Biospec 11 
Products) for 1 minute at maximal speed to separate cell chains into individual cells. 12 
Two hours later (end log-phase) another sample was measured. GFP fluorescence was 13 
measured using a Coulter Epics XL-MCL flow cytometer (Beckman Coulter).  14 
Average fluorescence of 20,000 cells was determined using WinMDI 2.8 15 
(http://facs.scripps.edu/software.html), and plotted against IPTG-concentrations (fig. 16 
2). As shown in Fig. 2, GFP expression under the control of PabrB is high without 17 
inducer, but is strongly reduced upon increasing levels of 0A*. When the native 18 
spo0A gene is deleted, GFP expression is further increased. Maximum concentration 19 
of GFP in this strain was quantified by SDS-PAGE relative to BSA standards. Dry 20 
matter concentrations of biomass were calculated using a predetermined correlation 21 
factor of 0.33 g cellular dry weight per OD600 nm unit (19). The concentration of GFP 22 
with an average fluorescence per cell of 550 AU was 16.7mg GFP/g dry weight. 23 
Interestingly, under inducing conditions (in the presence of 0A*), PabrB is more tightly 24 
repressed in the spo0A (∆0A) mutant. In the wild type strain the abrB promoter is still 25 
4 
leaky, and shows optimal de-repression of abrB when 0A* is induced with 50µM 1 
IPTG.  2 
Secretion of Clostridium perfringens β-toxoid 3 
To examine whether the system also enables the controlled expression of a secreted 4 
heterologous protein, we placed the gene encoding the Clostridium perfringens β-5 
toxin (cpb) behind the abrB promoter and combined this construct with the strain 6 
carrying the spo0A mutation (∆0A) and the inducible 0A*.  7 
The full coding sequence for β-toxin (cpb) was amplified by PCR with plasmid 8 
pXB10 as a template. C. perfringens β-toxin is a secreted protein with a Sec-type 9 
signal sequence and is an important vaccine component in animal vaccines against C. 10 
perfringens type B and C (7).  11 
To visualize β-toxin secretion, total medium proteins were 10x concentrated 12 
by TCA precipitation and separated by SDS-PAGE as described (14). β-toxin was 13 
detected using Western Blotting as described (7). As shown in Fig. 3A, at high IPTG 14 
induction levels, no β-toxin could be detected. Upon de-repression from 0A*, β-toxin 15 
accumulates in the growth medium.  These results show the versatility of the de-16 
repression system and that (heterologous) gene expression can be accurately 17 
controlled.  18 
To examine whether the described de-repression system can be activated in 19 
cultures with a high cellular density, which is required when producing toxic 20 
products, we grew strains A-β (PabrB-cpb) and A-β/0A*/∆0A (PabrB-cpb, Pspac-0A*, 21 
∆spo0A) to dense cultures in TY medium containing 250 µM IPTG (full repression). 22 
Next, cells were spun down, washed once, and resuspended in fresh TY without 23 
IPTG. Medium fractions were collected at timely intervals and assayed for β-toxin 24 
secretion. As shown in Fig. 3B, within 20 minutes after resuspension, PabrB is de-25 
5 
repressed in A-β/0A*/∆0A and β-toxin can be detected in the growth medium. β-toxin 1 
continues to accumulate in the medium up to 2h after de-repression in this dense 2 
culture, and we were able to recover β-toxin until 5.5h after suspension. In the 3 
presence of a functional spo0A gene however, secreted protein could not be observed 4 
anymore after 3.5h. 5 
abrB de-repression results in reduced extracellular proteolytic activity. 6 
Our results show that secreted β-toxin is more actively degraded in the presence of a 7 
functional spo0A gene. Many of the known extracellular proteases are either under 8 
direct or indirect control of Spo0A (6). To examine whether the increased degradation 9 
of β-toxin is related to increased extracellular proteolytic activity, we assayed the 10 
growth medium for proteolytic activity. Total protease activity was measured using 11 
the Roche resorufin labelled universal protease substrate as described by the 12 
manufacturer. Direct optical readout of the OD574 was plotted. As depicted in Fig. 3C, 13 
only a minor proteolytic activity was measured in ∆spo0A. In the presence of spo0A, 14 
strong protease activity can be observed starting after 150 minutes of resuspension in 15 
fresh medium, when cells enter stationary growth phase (data not shown).  16 
Induction and deletion of spo0A 17 
The use of sporulation deficient mutants (such as ∆0A) is common practise for large 18 
scale high-density fermentation processes, mainly because it prevents the formation of 19 
spores that are hard to remove from the growth system (9). Strain stability is not an 20 
issue for these mutants since sporulation is purely an adaptive phenotype and not 21 
essential. Addition of IPTG in our 0A* strain leads to induction of Spo0A and 22 
therefore undesirable sporulation could occur more rapidly. However, we did not 23 
observe sporulation under our culture conditions. The process of sporulation is tightly 24 
controlled and when only spo0A is induced during logarithmic growth not all essential 25 
6 
components for sporulation are expressed, preventing premature sporulation of the 1 
culture (2).  2 
Concluding remarks 3 
In this paper we show how a natural occurring gene-regulatory network can be 4 
adapted to serve as a tailored expression system. An additional benefit of using this 5 
endogenous pathway is that the system is based on self-cloning via homologous 6 
recombination, keeping the introduced foreign DNA to a minimum. Furthermore, 7 
upon activation of the abrB promoter extracellular proteolytic activity is reduced. 8 
 9 
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LEGENDS TO THE FIGURES 1 
Figure 1. Sporulation-based de-repression system 2 
Simplified schematic representation of the regulatory network that is used in this 3 
study. Perpendiculars and arrows represent the negative and positive actions 4 
respectively. 0A* represents Pspac-spo0A-sad67. High levels of IPTG induce 0A*, 5 
which represses PabrB. AbrB and the protein of interest are not produced and there is 6 
no repression of the extracellular proteases. If IPTG is absent, 0A* is not produced, 7 
PabrB is active yielding high levels of AbrB and the protein of interest while AbrB 8 
concomitantly represses the extracellular proteases.  9 
 10 
Figure 2. Controlled activation of PabrB-gfp via de-repression 11 
Expression of 0A* was induced with varying concentrations of IPTG. PabrB expression 12 
was measured during mid exponential growth (A) and end-exponential growth (B) 13 
using a PabrB-gfp fusion. Expression of PabrB-gfp in the presence and absence of 14 
endogenous spo0A was measured (strains 0A*/A-gfp and 0A*/∆0A/A-gfp). The units 15 
for GFP fluorescence are identical in panel A and B. 16 
 17 
Figure 3. Controlled secretion of PabrB-β-toxin via de-repression; abrB de-18 
repression results in reduced extracellular proteolytic activity. 19 
A: Detection of secreted 35kD β-toxin by strain 0A*/∆0A/A-β (PabrB-cpb, Pspac-0A*, 20 
∆spo0A) 21 
B :Detection of secreted 35kD β-toxin by strains 0A*/∆0A/A-β (PabrB-cpb, Pspac-0A*, 22 
∆spo0A) and A-β (PabrB-cpb). T0 is directly after resuspension in fresh medium. The 23 
increased background in later time points of 0A*/∆0A/A-β is caused by cross reaction 24 
8 
of the β-toxin antibody to some intracellular proteins released to the medium by cell 1 
lysis. 2 
C: Extracellular proteolytic activity of the cultures depicted in 3B.  3 
 4 
TABLE 1. Bacterial strains and plasmids 5 
Strains  Relevant properties Reference 
E. coli   
MC1061 F-, araD139, ∆(ara-leu)7696, ∆(lac)X74, galU, 
galK, hsdR2, mcrA, mcrB1, rspL 
(18) 
   
B. subtilis   
168 trpC2 (4) 
SWV215 spo0A::Km (20) 
0A* (sad67::Tc) amyE::Pspac-spo0A-sad67, Tcr (16) 
A-gfp (abrB-GFP) PabrB-gfp, Cmr (17) 
0A*/A-gfp amyE::Pspac-spo0A-sad67; PabrB-gfp, Cmr, Tcr This study 
∆0A/A-gfp spo0A::Km; PabrB-gfp, Cmr , Kmr This study 
0A*/∆0A/A-gfp amyE::Pspac-spo0A-sad67; spo0A::Km; PabrB-gfp, 
Cmr, Tcr, Kmr 
This study 
A-β PabrB-cpb, Cmr  This study 
0A*/A-β amyE::Pspac-spo0A-sad67; PabrB-cpb, Cmr, Tcr This study 
∆0A/A-β spo0A::Km; PabrB-cpb, Cmr, Kmr This study 
0A*/∆0A/A-β amyE::Pspac-spo0A-sad67, spo0A::Km, PabrB-cpb, 
Cmr, Tcr, Kmr 
This study 
   
Plasmids   
pSG1151 bla cat gfp (5) 
pXB10 pUB110 containing β-toxin coding region (15)  
pPabrB-cpb bla, cat, PabrB-cpb This study 
 6 
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TABLE 1. Bacterial strains and plasmids 
Strains  Relevant properties Reference 
E. coli   
MC1061 F-, araD139, ∆(ara-leu)7696, ∆(lac)X74, galU, 
galK, hsdR2, mcrA, mcrB1, rspL 
(31) 
   
B. subtilis   
168 trpC2 (9) 
SWV215 spo0A::Km (33) 
0A* (sad67::Tc) amyE::Pspac-spo0A-sad67, Tcr (28) 
A-gfp (abrB-GFP) PabrB-gfp, Cmr (29) 
0A*/A-gfp amyE::Pspac-spo0A-sad67; PabrB-gfp, Cmr, Tcr This study 
∆0A/A-gfp spo0A::Km; PabrB-gfp, Cmr , Kmr This study 
0A*/∆0A/A-gfp amyE::Pspac-spo0A-sad67; spo0A::Km; PabrB-gfp, 
Cmr, Tcr, Kmr 
This study 
A-β PabrB-cpb, Cmr  This study 
0A*/A-β amyE::Pspac-spo0A-sad67; PabrB-cpb, Cmr, Tcr This study 
∆0A/A-β spo0A::Km; PabrB-cpb, Cmr, Kmr This study 
0A*/∆0A/A-β amyE::Pspac-spo0A-sad67, spo0A::Km, PabrB-cpb, 
Cmr, Tcr, Kmr 
This study 
   
Plasmids   
pSG1151 bla cat gfp (12) 
pXB10 pUB110 containing β-toxin coding region (26)  
pPabrB-cpb bla, cat, PabrB-cpb This study 
 
 TABLE 2. Oligonucleotides used in this study 
Oligonucleotide Sequence (5’ to 3’)a Description; position 
AbrB-F+ClaI CGCATCGATTCTTGAAACCTCCTAA
TCAGAATGTC 
ClaI; 5’ end of PabrB 
AbrB-R-NdeI GGGAATTCCATATGCATTCTCCTCC
CAAGAGATACTTATTTG 
NdeI; 3’ end of PabrB 
Btox-RN1-fw GCGTCTAGACATATGAAGAAAAAA
TTTATTTCATTAGTTATAG 
NdeI, 5’ end of β-toxin 
Btox-RN2-rv CGCTCTAGATTAAATAGCTGTTACT
TTGTGAG 
XbaI, 3’ end of β-toxin 
a
 Relevant restriction sites are underlined. 
 
 
 
 
 
